Foghorn Therapeutics Inc. - FHTX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND L P | 5.4% | 3,164,410 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF I GP LLC | 5.4% | 3,164,410 | View |
| May 15, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND II LP | 3.8% | 2,218,382 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF II GP LLC | 3.8% | 2,218,382 | View |
| May 15, 2026 | SCHEDULE 13G/A | Biotechnology Value Trading Fund OS LP | 0.7% | 402,467 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF Partners OS Ltd. | 0.7% | 402,467 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF GP HOLDINGS LLC | 9.2% | 5,382,792 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF PARTNERS L P/IL | 9.99% | 5,866,613 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF INC/IL | 9.99% | 5,866,613 | View |
| May 15, 2026 | SCHEDULE 13G/A | LAMPERT MARK N | 9.99% | 5,866,613 | View |
| May 14, 2026 | SCHEDULE 13G/A | Deerfield Mgmt, L.P. | 8.64% | 5,139,523 | View |
| May 14, 2026 | SCHEDULE 13G/A | Deerfield Management Company, L.P. | 8.64% | 5,139,523 | View |
| May 14, 2026 | SCHEDULE 13G/A | Deerfield Partners, L.P. | 8.64% | 5,139,523 | View |
| May 14, 2026 | SCHEDULE 13G/A | James E. Flynn | 8.64% | 5,139,523 | View |
| May 06, 2026 | SCHEDULE 13G/A | FMR LLC | 11.6% | 6,792,356 | View |
| May 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 11.6% | 6,792,356 | View |
| Jan 13, 2026 | SCHEDULE 13D/A | — | 9.99% | 2,024 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.